As of Nov 22
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +116.04% increase from the last price of 1.62.
The current consensus among 1 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.